sulfaphenazole has been researched along with Cancer of Liver in 2 studies
Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, D | 1 |
| Kang, JA | 1 |
| Lim, C | 1 |
| Bae, S | 1 |
| Choi, J | 1 |
| Park, M | 1 |
| Kim, YC | 1 |
| Cho, Y | 1 |
| Park, SG | 1 |
| Seo, J | 1 |
| Myung, SJ | 1 |
| Yoon, JH | 1 |
| Yu, SJ | 1 |
2 other studies available for sulfaphenazole and Cancer of Liver
| Article | Year |
|---|---|
Entry inhibition of hepatitis B virus using cyclosporin O derivatives with peptoid side chain incorporation.
Topics: Antiviral Agents; Cyclosporins; Hepatitis B; Hepatitis B virus; Humans; Imidazoles; Liver Neoplasms; | 2022 |
STAT3 & Cytochrome P450 2C9: a novel signaling pathway in liver cancer stem cells.
Topics: Antineoplastic Agents; Apoptosis; Aryl Hydrocarbon Hydroxylases; Carcinoma, Hepatocellular; Cell Hyp | 2012 |